Microcirculation Guided Therapy Versus "Standard Treatment" of Severe Sepsis
NCT00484133 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2008-01-22
Summary
The purpose of this study is to asses the recovery of organ failure between two resuscitation protocols in severe sepsis: standard, pressure guided therapy versus a microcirculation guided therapy
Conditions
- Severe Sepsis
- Microcirculation
Interventions
- DRUG
-
Dopamine
- DRUG
-
dobutamine
- DRUG
-
enoximone
- DRUG
-
nitroglycerine
- DRUG
-
noradrenaline
Sponsors & Collaborators
-
Onze Lieve Vrouwe Gasthuis
lead OTHER
Principal Investigators
-
Rutger v Raalte, MD · Onze Lieve Vrouwe Gasthuis, intensive care unit
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2008-12-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Resuscitation Strategies in Septic Shock
NCT02150512 ·Status: UNKNOWN ·Phase: NA
-
Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock
NCT04870892 ·Status: UNKNOWN
-
Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock
NCT00604019 ·Status: COMPLETED ·Phase: PHASE3
-
Fluid Management and Individualized Resuscitation in Sepsis
NCT07009665 ·Status: RECRUITING ·Phase: NA
-
An Open Label Study of Severe Sepsis in Adults
NCT00568893 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of a Tissue Perfusion Guided Hemodynamic Protocol With a Standard Hemodynamic Protocol in Septic Shock Patients
NCT01296789 ·Status: TERMINATED ·Phase: NA
-
Adjuvant Therapy With CytoSorb in Refractory Septic Shock
NCT04013269 ·Status: UNKNOWN ·Phase: NA
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Dopexamine and Norepinephrine Compared With Epinephrine Alone in Septic Shock
NCT00134212 ·Status: COMPLETED ·Phase: PHASE2
-
Microcirculatory Guided Goal Directed Fluid Therapy in Septic Shock; a Feasibility Study
NCT03898674 ·Status: UNKNOWN ·Phase: NA
-
Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis
NCT00406198 ·Status: COMPLETED ·Phase: PHASE4
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
Systematic Adjunction of Vasopressine in Septic Shock
NCT07052084 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic Shock
NCT00148278 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Adrenomedullin and Outcome in Severe Sepsis and Septic Shock
NCT02393781 ·Status: COMPLETED
-
Hemodynamic Optimisation Guided With Transcranial Doppler in Septic Shock
NCT04398069 ·Status: UNKNOWN ·Phase: NA
-
Acute Phase Proteins as Early Markers in Sepsis
NCT00641355 ·Status: UNKNOWN
-
Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic Patients
NCT05080543 ·Status: UNKNOWN ·Phase: PHASE1
-
Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
NCT02062970 ·Status: UNKNOWN ·Phase: NA
-
Hemodynamic Phenotype and Capillary Refill Time-targeted Resuscitation Strategy
NCT05057611 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
NCT00604214 ·Status: COMPLETED ·Phase: PHASE3
-
Citrulline in Severe Sepsis
NCT01474863 ·Status: COMPLETED ·Phase: PHASE2
-
Activated Protein C and Microcirculation
NCT01806428 ·Status: COMPLETED
-
Methylene Blue and Microcirculation in Septic Shock
NCT04295993 ·Status: UNKNOWN ·Phase: PHASE3
-
Microcirculatory Alterations in Critical Disease: New Ultrasound Technology
NCT03311568 ·Status: TERMINATED ·Phase: NA